Examining the Latest Litigation Against PBMs

June 10, 2021 3:45pm

Richard J. Merino
Senior Managing Director
Ankura Consulting Group

  • Examining the supreme court decision in Rutledge v. Pharmaceutical Care Management Association
    • How the decision to uphold the Arkansas Act and dismiss ERISA pre-emption will impact PBM drug price setting
  • Examining recent opioid related claims asserted against PBMs—and the projected impact, more broadly for drug litigation
  • Anticipating new legislative and regulations on drug pricing